Sunday, November 1, 2026

UN Security Council Scrambles After North Korean Satellite Disaster

Contrary to initial reports, the United Nations...

Trade War not Over: How New Regulations Could Impact Global Freight Costs

The U.S.-China shipping conflict escalates as China imposes retaliatory measures, risking long-term impacts on cargo volumes and rates.

Trump’s Tariff Barrage & Fed Pressure Trigger an Exodus of Funds, Brains from US

Trump's policies are driving global funds and skilled professionals away from the U.S., leading to a significant brain drain.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Kangstem Biotech Signs Organoid Technology Evaluation Agreement With Global Top Five Pharmaceutical Company

Kangstem Biotech has signed an agreement with a top pharmaceutical company to evaluate drug candidates using its hair follicle organoid platform.

Managing Cancer Pain: Essential Strategies for Comfort and Recovery

Effective pain management is crucial for cancer patients, enhancing treatment outcomes and quality of life. Early intervention is key.

2026 Breakthrough in Medical Imaging: Discover How New Polymer ICG Improves Fluorescence Stability

A study improves near-infrared dye stability for tumor imaging, enhancing medical diagnostics by reducing fluorescence loss during procedures.

Unlocking the Mystery: How Anti-CTLA-4 Boosts B Cell Response Against Brain Tumors

Researchers reveal that B cells, not just T cells, are crucial for the success of immune checkpoint inhibitors in treating glioblastoma.

“We Treat Patients’ Lives, Not Just Cancer” — The Future of Cancer Care Led by a Breast Cancer Pioneer [K-Medical Report]

A compassionate approach to cancer treatment, emphasizing emotional support and tailored care, leads to high survival rates and patient satisfaction.

South Korea Eases Phase 3 Trial Requirements for Biosimilars Following U.S. and EU… Early Data Becomes Key Battleground

South Korea's MFDS eases Phase 3 trial requirements for biosimilars, aligning with global trends, enhancing early comparability importance.

HLB’s Liver Cancer Drug: FDA’s VAI Conclusion Sparks Hope for Approval

HLB's Rivoceranib facility passed FDA inspection, receiving VAI classification, moving towards new liver cancer drug approval.

How Salidroside from Korean Ginseng Can Combat Insulin Resistance and Prevent Diabetes

Research reveals salicin from tianma improves insulin resistance, aiding diabetes prevention and intestinal health restoration.

Smoking Raises Fatty Liver Risk by Up to 1.5 Times Among Young Adults

Young adult smokers face a higher risk of fatty liver disease, with significant findings on its impact regardless of obesity or alcohol consumption.

[Exclusive] HLB’s Liver Cancer Drug Clears Camrelizumab CMC Review, but Hengrui Manufacturing Facility Becomes New Hurdle

HLB's liver cancer drug approval faces delays due to FDA findings at Hengrui's facility, despite resolution of previous issues.

U.S. pharmaceutical companies’ China clinical trial security probe to conclude this week… Could biotech rivalry intensify?

A U.S. investigation into pharmaceutical trials in China may reshape global biotech strategies, impacting South Korean firms.

“Automation Alone Isn’t Enough”: Hugel Executive Highlights the Company’s Quality-First Manufacturing Strategy

Hugel's Geodu facility expands botulinum toxin production while prioritizing consistent quality over volume, ensuring global market compliance.

Shaperon Secures South Korean Patent for Pulmonary Fibrosis Drug Candidate NuPulin

Shaperon secures a South Korean patent for NuPulin, an oral drug for idiopathic pulmonary fibrosis, showing promising preclinical results.

How ATF4 and CHOP Proteins Decide Cell Fate: Key Discoveries in Stress Response

Researchers identified how genetic mechanisms determine cell survival or death under stress, revealing insights for disease treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.